Vicapsys Life Sciences, Inc. (VICP)
| Market Cap | 25.41M -55.6% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 32.37M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,230 |
| Open | 0.2323 |
| Previous Close | 0.7850 |
| Day's Range | 0.2323 - 0.8500 |
| 52-Week Range | 0.1500 - 1.7500 |
| Beta | 416,757.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About Vicapsys Life Sciences
Vicapsys Life Sciences, Inc. operates as a specialty pharmaceutical wholesale distributor. The company supports pharmacies with pharmaceutical and medical equipment, products and vials. It serves all states in the United States. The company is based in Guaynabo, Puerto Rico. [Read more]
Financial Performance
Financial StatementsNews
Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger
Advisors bring experience across federal government, tribal governance and economic development, pharmaceutical development and manufacturing, oncology in Puerto Rico, international financial operatio...
RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets
Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party l...
Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets
Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party l...
ViCapsys Life Sciences Appoints Three New Board Members
Mr. Richard Rosenblum, Dr. Colleen Delaney, and Mr. Charles Farrahar Appointed to the Board of Directors Bring a Combined 75 Years of Financial and Pharmaceutical Expertise SUWANEE, GA / ACCESSWIRE / ...